Transport of nanoparticles and tobramycin-loaded liposomes in Burkholderia cepacia complex biofilms

PLoS ONE

Volumn 8, Issue 11, 2013, Pages

  Messiaen, Anne Sophie ^a   Forier, Katrien ^a   Nelis, Hans ^a   Braeckmans, Kevin ^a   Coenye, Tom ^a  

^a GHENT UNIVERSITY   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

ANTI-BACTERIAL AGENTS; BIOFILMS; BIOLOGICAL TRANSPORT; BURKHOLDERIA CEPACIA; DRUG DELIVERY SYSTEMS; LIPOSOMES; NANOPARTICLES; TOBRAMYCIN;

EID: 84893642858     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0079220     Document Type: Article

References (31)

1. O'Sullivan BP, Freedman SD (2009) Cystic fibrosis. Lancet 373: 1891-1904.
2. Brennan AL, Geddes DM (2002) Cystic fibrosis. Curr Op Infect Dis 15: 175-182. (Pubitemid 34271162)
3. Lyczak JB, Cannon CL, Pier GB (2002) Lung infections associated with cystic fibrosis. Clin Microbiol Rev 15: 194-222. (Pubitemid 34303763)
4. Cystic Fibrosis Foundation (2011) Annual data report to the center directors. Bethesda, Maryland: Cystic Fibrosis Foundation patient registry.
5. Mahenthiralingam E, Urban TA, Goldberg JB (2005) The multifarious, multireplicon Burkholderia cepacia complex. Nature Rev Microbiol 3: 144-156. (Pubitemid 40207595)
6. Zlosnik JE, Costa PS, Brant R, Mori PY, Hird TJ, et al. (2011) Mucoid and nonmucoid Burkholderia cepacia complex bacteria in cystic fibrosis infections. Am K Resp Crit Care Med 183: 67-72.
7. Horsley A, Jones AM (2012) Antibiotic treatment for Burkholderia cepacia complex in people with cystic fibrosis experiencing a pulmonary exacerbation. Cochrane Database Syst Rev 10: CD009529.
8. Sousa SA, Ramos CG, Leitao JH (2011) Burkholderia cepacia complex: emerging multihost pathogens equipped with a wide range of virulence factors and determinants. Int J Microbiol doi: 10.1155/2011/607575.
9. Cunha MV, Sousa SA, Leitao JH, Moreira LM, Videira PA, et al. (2004) Studies on the involvement of the exopolysaccharide produced by cystic fibrosis-associated isolates of the Burkholderia cepacia complex in biofilm formation and in persistence of respiratory infections. J Clin Microbiol 42: 3052-3058. (Pubitemid 38938057)
10. Tseng BS, Zhang W, Harrison JJ, Quach TP, Song JL, et al. (2013) The extracellular matrix protects Pseudomonas aeruginosa biofilms by limiting the penetration of tobramycin. Env Microbiol doi: 10.1111/1462-2920.12155.
11. Giwercman B, Jensen ET, Hoiby N, Kharazmi A, Costerton JW (1991) Induction of beta-lactamase production in Pseudomonas aeruginosa biofilm. Antimicrob Agents Chemother 35: 1008-1010.
12. Nikaido H (1989) Outer membrane barrier as a mechanism of antimicrobial resistance. Antimicrob Agents Chemother 33: 1831-1836.
13. Nikaido H (1994) Prevention of drug access to bacterial targets: permeability barriers and active efflux. Science 264: 382-388.
14. Hancock RE (1998) Resistance mechanisms in Pseudomonas aeruginosa and other nonfermentative gram-negative bacteria. Clin Infect Dis 27 Suppl 1: S93-99.
15. Mugabe C, Halwani M, Azghani AO, Lafrenie RM, Omri A (2006) Mechanism of enhanced activity of liposome-entrapped aminoglycosides against resistant strains of Pseudomonas aeruginosa. Antimicrob Agents Chemother 50: 2016-2022. (Pubitemid 43807520)
16. Beaulac C, Sachetelli S, Lagace J (1998) In-vitro bactericidal efficacy of sub-MIC concentrations of liposome-encapsulated antibiotic against gram-negative and gram-positive bacteria. J Antimicrob Chemother 41: 35-41. (Pubitemid 28064248)
17. Mugabe C, Azghani AO, Omri A (2005) Liposome-mediated gentamicin delivery: development and activity against resistant strains of Pseudomonas aeruginosa isolated from cystic fibrosis patients. J Antimicrob Chemother 55: 269-271. (Pubitemid 40331158)
18. Halwani M, Mugabe C, Azghani AO, Lafrenie RM, Kumar A, et al. (2007) Bactericidal efficacy of liposomal aminoglycosides against Burkholderia cenocepacia. J Antimicrob Chemother 60: 760-769. (Pubitemid 47434253)
19. Chang HI, Yeh MK (2012) Clinical development of liposome-based drugs: formulation, characterization, and therapeutic efficacy. Int J Nanomed 7: 49-60.
20. Li Z, Zhang Y, Wurtz W, Lee JK, Malinin VS, et al. (2008) Characterization of nebulized liposomal amikacin (Arikace) as a function of droplet size. J Aerosol Med Pulm Drug Del 21: 245-254.
21. Symens N, Walczak R, Demeester J, Mattaj I, De Smedt SC, et al. (2011) Nuclear inclusion of nontargeted and chromatin-targeted polystyrene beads and plasmid DNA containing nanoparticles. Mol Pharm 8: 1757-1766.
22. Braeckmans K, Buyens K, Bouquet W, Vervaet C, Joye P, et al. (2010) Sizing nanomatter in biological fluids by fluorescence single particle tracking. Nano Lett 10: 4435-4442.
23. Braeckmans K, Vercauteren D, Demeester J, De Smedt SC (2010) Single particle tracking. In: Diaspor A, editor. Nanoscopy and multidimensional optical fluorescence microscopy. Boca Raton: Chapman & Hall/CRC. 1-17.
24. Mugabe C, Azghani AO, Omri A (2006) Preparation and characterization of dehydration-rehydration vesicles loaded with aminoglycoside and macrolide antibiotics. Int J Pharm 307: 244-250. (Pubitemid 41820421)
25. EDQM (2005) European Pharmacopoeia. 5th ed. Strasbourg, France: EDQM.
26. Forier K, Messiaen AS, Raemdonck K, Deschout H, Rejman J, et al. (2013) Transport of nanoparticles in cystic fibrosis sputum and bacterial biofilms by single-particle tracking microscopy. Nanomed 8: 935-949.
27. Peeters E, Nelis HJ, Coenye T (2009) In vitro activity of ceftazidime, ciprofloxacin, meropenem, minocycline, tobramycin and trimethoprim/sulfa- methoxazole against planktonic and sessile Burkholderia cepacia complex bacteria. J Antimicrob Chemother 64: 801-809.
28. Omri A, Suntres ZE, Shek PN (2002) Enhanced activity of liposomal polymyxin B against Pseudomonas aeruginosa in a rat model of lung infection. Biochem Pharmacol 64: 1407-1413. (Pubitemid 35248257)
29. Meers P, Neville M, Malinin V, Scotto AW, Sardaryan G, et al. (2008) Biofilm penetration, triggered release and in vivo activity of inhaled liposomal amikacin in chronic Pseudomonas aeruginosa lung infections. J Antimicrob Chemother 61: 859-868. (Pubitemid 351426071)
30. Seidler M, Salvenmoser S, Muller FM (2010) Liposomal amphotericin B eradicates Candida albicans biofilm in a continuous catheter flow model. FEMS Yeast Res 10: 492-495.
31. Novotny LA, Amer AO, Brockson ME, Goodman SD, Bakaletz LO (2013) Structural stability of Burkholderia cenocepacia biofilms in reliant on eDNA structure and presence of a bacterial nucleic acid binding protein. PloS One 8: e67629.